Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia.
about
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@en
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@nl
type
label
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@en
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@nl
prefLabel
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@en
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Inotuzumab ozogamicin in the t ...... B cell lymphoblastic leukemia.
@en
P2093
Amer M Zeidan
Maximilian Stahl
Michelle Nadeau
Natalie Uy
P2860
P356
10.2147/JBM.S136575
P577
2018-04-13T00:00:00Z